交易日期 |
标的证券代码 |
标的证券名称 |
融资 |
融券 |
融资融券余额(元) |
融资买入额(元) |
融资偿还额(元) |
融资余额(元) |
融券卖出量(股) |
融券偿还量(股) |
融券余量(股) |
融券余额(元) |
2024-04-26 |
603127 |
昭衍新药 |
22,161,683 |
34,128,470 |
430,561,728 |
138,400 |
50,700 |
2,346,909 |
40,765,811 |
471,327,539 |
2024-04-25 |
603127 |
昭衍新药 |
30,175,082 |
16,492,799 |
442,528,515 |
52,600 |
112,630 |
2,259,209 |
38,203,224 |
480,731,739 |
2024-04-24 |
603127 |
昭衍新药 |
19,866,265 |
23,329,708 |
428,846,232 |
47,920 |
43,800 |
2,319,239 |
39,543,023 |
468,389,255 |
2024-04-23 |
603127 |
昭衍新药 |
31,561,439 |
22,336,869 |
432,309,675 |
244,200 |
53,300 |
2,315,119 |
40,514,582 |
472,824,258 |
2024-04-22 |
603127 |
昭衍新药 |
11,704,190 |
11,667,382 |
423,085,105 |
51,441 |
201,300 |
2,124,219 |
36,047,995 |
459,133,100 |
2024-04-19 |
603127 |
昭衍新药 |
15,327,469 |
18,268,686 |
423,048,297 |
197,400 |
79,300 |
2,274,078 |
38,159,030 |
461,207,327 |
2024-04-18 |
603127 |
昭衍新药 |
18,591,910 |
25,988,626 |
425,989,514 |
395,480 |
150,628 |
2,155,978 |
37,664,934 |
463,654,448 |
2024-04-17 |
603127 |
昭衍新药 |
37,799,270 |
35,121,925 |
433,386,230 |
187,900 |
53,300 |
1,911,126 |
33,941,598 |
467,327,828 |
2024-04-16 |
603127 |
昭衍新药 |
22,838,798 |
23,607,693 |
430,708,885 |
227,200 |
272,300 |
1,776,526 |
29,525,864 |
460,234,749 |
2024-04-15 |
603127 |
昭衍新药 |
23,266,134 |
17,031,762 |
431,477,780 |
93,200 |
484,104 |
1,821,626 |
32,388,512 |
463,866,292 |
2024-04-12 |
603127 |
昭衍新药 |
31,536,221 |
32,675,253 |
425,243,408 |
157,265 |
17,100 |
2,212,530 |
40,599,926 |
465,843,334 |
2024-04-11 |
603127 |
昭衍新药 |
23,445,360 |
29,507,537 |
426,382,440 |
111,700 |
129,460 |
2,072,365 |
39,582,172 |
465,964,612 |
2024-04-10 |
603127 |
昭衍新药 |
52,227,656 |
63,955,130 |
432,444,617 |
280,100 |
145,791 |
2,090,125 |
40,130,402 |
472,575,019 |
2024-04-09 |
603127 |
昭衍新药 |
22,879,872 |
41,492,709 |
444,172,091 |
250,728 |
25,100 |
1,955,816 |
37,082,270 |
481,254,361 |
2024-04-08 |
603127 |
昭衍新药 |
24,503,705 |
26,176,112 |
462,784,928 |
38,500 |
245,300 |
1,730,188 |
29,828,441 |
492,613,369 |
2024-04-03 |
603127 |
昭衍新药 |
16,403,888 |
20,965,503 |
464,457,335 |
98,200 |
14,612 |
1,936,988 |
34,904,525 |
499,361,860 |
2024-04-02 |
603127 |
昭衍新药 |
19,752,367 |
14,687,297 |
469,018,950 |
195,304 |
39,000 |
1,853,400 |
34,176,697 |
503,195,647 |
2024-04-01 |
603127 |
昭衍新药 |
24,458,286 |
27,521,368 |
463,953,880 |
188,120 |
168,736 |
1,697,096 |
32,007,232 |
495,961,112 |
2024-03-29 |
603127 |
昭衍新药 |
21,348,390 |
24,480,450 |
467,016,962 |
200,580 |
20,500 |
1,677,712 |
30,333,033 |
497,349,995 |